The Use of Fas Ligand, TRAIL and Bax in Gene Therapy of Prostate Cancer
Journal:
Current Gene Therapy
Volume:
1
Page:
123-136
Author(s):
J. S. Norris, M. L. Hyer, C. Voelkel-Johnson, S. L. Lowe, S. Rubinchik and J-Y. Dong
An Approach to the Rational Design of Opioid Receptor Ligands Non-narcotic k-Opioid Receptor Ligand KT-95 Free from Euphoria and or Dysphoria
Journal:
Current Medicinal Chemistry - Central Nervous System Agents
Volume:
1
Page:
1-25
Author(s):
Ken Kanematsu and Takeshi Sagara
Preface
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
i-i
Author(s):
Michelle Prudhomme
Prostate Cancer Horizons in the Development of Novel Anti-Cancer Strategies
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
47-70
Author(s):
A. G. Papatsoris and A. G. Papavassiliou
Peptides as Carrier for Tumor Diagnosis and Treatment
Journal:
Current Medicinal Chemistry - Anti-Cancer Agents
Volume:
1
Page:
71-93
Author(s):
M. Langer and A. G. Beck-Sickinger
Preface
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
i-i
Author(s):
Michael J. Quon and Emilio Jirillo
Estrogens and Colorectal Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
1
Page:
1-12
Author(s):
A. Di Leo, C. Messa, A. Cavallini and M. Linsalata
Central Self - Tolerance by Thymic Presentation of Self - Antigens and Autoimmunity
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
47-60
Author(s):
Vincent Geenen, Henri Martens, Fabienne Brilot, Isabelle Hansenne and Ouafae Kecha-Kamoun
Nutritional Antioxidants Mechanisms of Action, Analyses of Activities and Medical Applications
Journal:
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents
Volume:
1
Page:
99-117
Author(s):
Jacob Vaya and Michael Aviram
Preface
Journal:
Current Drug Targets
Volume:
2
Page:
i-i
Author(s):
Moshe Szyf